iSpecimen Inc. (ISPC) 8-K Summary

iSpecimen Inc. announced the results of its October 30, 2025, Special Meeting where all proposals were approved by stockholders.

Key investor impacts:

• Capital Structure:
  • Approved a Reverse Stock Split (ratio 1:10 to 1:100, TBD by Board).
  • Authorized shares increased significantly, from 250 million to 1 billion.
• Financing Flexibility & Dilution:
  • Approved potential issuances in private financing transactions exceeding 19.99% of outstanding shares for Nasdaq compliance (Rule 5635(d)).
  • Approved enteri